Showing results (1791-1800 of 1,902) with videos related to

Sort By:
Pageof 191
Radiation Oncology (London, England)|September 11, 2017
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old, Salman A Eraj, Mona K Jomaa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Impacts of fire and prospects for recovery in a tropical peat forest ecosystemMark E Harrison, Nicolas J Deere, Muhammad Ali Imron, et al.
Research Square|November 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopeniasMark P Hamilton, Nick Phillips, Troy Noordenbos, et al.
Cancer Cell|December 30, 2022
Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomasBrian J Sworder, David M Kurtz, Stefan K Alig, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 13, 2025
Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohortsLaia Humbert-Vidan, Serageldin Kamel, Andrew Wentzel, et al.
Blood Advances|August 5, 2025
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysisZachary D Epstein-Peterson, Anath Christopher Lionel, Ashlee Joseph, et al.
Clinical and Translational Radiation Oncology|November 3, 2018
Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trialHouda Bahig, Ying Yuan, Abdallah S R Mohamed, et al.
Nature Medicine|July 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJay Y Spiegel, Shabnum Patel, Lori Muffly, et al.
Lancet (London, England)|December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trialSteven J Frank, Paul M Busse, J Jack Lee, et al.
Translational Psychiatry|March 29, 2017
Genetic effects influencing risk for major depressive disorder in China and EuropeT B Bigdeli, S Ripke, R E Peterson, et al.
Pageof 191